We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Suit Says Sanofi Held Back Info On Obesity Drug

Law360 (January 3, 2008, 12:00 AM EST) -- French pharmaceutical giant Sanofi-Aventis has been hit with a putative securities class action accusing it and five individuals of withholding information about anti-obesity drug Zimulti's tendency to cause severe psychiatric problems, including suicidal thoughts and actions.

The complaint was dated Dec. 28 and was lodged in the U.S. District Court for the Southern District of New York. It named the company and five people who the plaintiff says had the power and authority to control Sanofi's reports to the U.S. Securities and Exchange Commission and its...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.